Substituted phenylcyclohexanecarboxamides and their use

Details Substituted phenylcyclohexanecarboxamides and their use Substituted phenylcyclohexanecarboxamides and their use

2006-07-11

2006-07-11

Raymond, Richard L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Heterocyclic carbon compounds containing a hetero ring...

C514S430000, C514S438000, C514S613000, C514S588000, C549S315000

Reexamination Certificate

active

07074780

ABSTRACT:
The present invention relates to substituted phenylcyclohexanecarboxamides of the formula (I)to processes for their preparation and to their use in medicaments, in particular for the prevention and/or treatment of cardiovascular disorders.

REFERENCES:
patent: 5607962 (1997-03-01), M uller-Gliemann et al.
patent: 0582164 (1994-02-01), None
patent: 0611767 (1994-08-01), None
patent: 611767 (1994-08-01), None
Becker, L. C., “Conditions for Vasodilator-Induced Coronary Steal in Experimental Myocardial Ischemia”, Circulation, 57 (6): 1103-1110 (1978).
DeNinno, M.P., “Annual Reports in Medicinal Chemistry”, 33: 111-120 (1998).
Makarewicz, W., “Response of Purine Metabolism to Hypoxia and Ischemia, Purine and Pyrimidine Matabolism in Man”, Plenum Press, New York, 11: 351-357 (1998).
Marangos, P.J et al., Potential Therapeutic Roles for Adenosine in Neurologic Disease, Adenosine in the Nervous System, Eds. Stone, T., Academic Press Ltd., p.p. 217-227 (1991).
Murray, T.F.et al., “Manipulation of Endogenous Adenosine Affects Seizure Susceptability”, Drug Development Research, 28, 410-415 (1993).
Porkka-Heiskanen, T. et al., “Adenosine: A Mediator of the Sleep-Inducing Effects of Prolonged Wakefulness”, Science, 276: 1265-1268 (1997).
Rudolphi, K. A. et al., “Adenosine and Brain Ischema”, Cerebrovascular and Brain Metabolism Review, 4: 346-369 (1992).
Strasser, R et al., Zeitschrift fur Kardologle, 85(2): 79-89 (1996).
Sear, J.W. et al., “Issues In the perioperative management of the elderly patient with cardiovascular disease”, Pub Med Abstract 12149050; Drugs Aging 19, 429-451 (2002).
Sawynok J. et al., Pharmacological rationale for the clinical use of caffeine, PubMed Abstract 7705215, Drugs, 49, 37-50 (1995).
Jurkowitz, M.S. et al., “Adenosine, inosine, and guanosine protect glial cells during glucose deprivation and mitochondrial inhibition: correlation between Protection and ATP preservation,” PubMed Abstract 9681443; J. Neurochem, 71, 535-548 (1998).

Affiliated with

Also associated with

Rating

Substituted phenylcyclohexanecarboxamides and their use does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Substituted phenylcyclohexanecarboxamides and their use, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted phenylcyclohexanecarboxamides and their use will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3529218